Eva L. Feldman

Schwann cell caveolin-1 expression increases during myelination and decreases after axotomy.

Insulin-like growth factor I prevents mannitol-induced degradation of focal adhesion kinase and Akt.

N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells.

Control of cell survival by IGF signaling pathways.

Update on diabetic neuropathy.

Signaling mechanisms that regulate actin-based motility processes in the nervous system.

High glucose-induced oxidative stress and mitochondrial dysfunction in neurons.

Neuronal survival following remote adenovirus gene delivery.

Intraneural colchicine inhibition of adenoviral and adeno-associated viral vector remote spinal cord gene delivery.

Oxidative stress and diabetic neuropathy: a new understanding of an old problem.

N-Myc overexpression leads to decreased beta1 integrin expression and increased apoptosis in human neuroblastoma cells.

Substrate patterning: an emerging technology for the study of neuronal behavior.

Microvascular complications of impaired glucose tolerance.

Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.

Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells.

Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery.

Insulin-like growth factor-I signaling in human neuroblastoma cells.

The role of growth factors in diabetic peripheral neuropathy.

Applying database technology to clinical and basic research bioinformatics projects.

Neuroinflammation, COX-2, and ALS--a dual role?

IGF-I prevents glutamate-induced motor neuron programmed cell death.

New insights into the mechanisms of diabetic neuropathy.

Integrin expression regulates neuroblastoma attachment and migration.

Oxidative stress in the pathogenesis of diabetic neuropathy.

Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons.

Establishment, maintenance, and transfection of in vitro cultures of human retinal pigment epithelium.

In situ imaging of mitochondrial outer-membrane pores using atomic force microscopy.

Polyneuropathy with Impaired Glucose Tolerance: Implications for Diagnosis and Therapy.

Integrin-linked kinase complexes with caveolin-1 in human neuroblastoma cells.

Short-term hyperglycemia produces oxidative damage and apoptosis in neurons.

Differential regulation of insulin receptor substrate-1 degradation during mannitol and okadaic acid induced apoptosis in human neuroblastoma cells.

Diabetic neuropathies: a statement by the American Diabetes Association.

Insulin-like growth factors in the treatment of neurological disease.

Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro.

Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.

New developments in diabetic neuropathy.

Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury.

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

Longitudinal assessment of noninvasive positive pressure ventilation adjustments in ALS patients.

Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1.

Lifestyle intervention for pre-diabetic neuropathy.

Evaluation of sham non-invasive ventilation for randomized, controlled trials in ALS.

Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone.

Biomedical research: a culture in crisis?

Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.

Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress.

Diabetic neuropathies.

Aligned electrospun nanofibers specify the direction of dorsal root ganglia neurite growth.

Dysfunction of the recurrent laryngeal nerve and the potential of gene therapy.

Mouse models of diabetic neuropathy.

SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

Can drug screening lead to candidate therapies for testing in diabetic neuropathy?

Kindlin-2 is an essential component of intercalated discs and is required for vertebrate cardiac structure and function.

Strategic approaches to developing drug treatments for ALS.

Diabetic neuropathy.

Criteria for creating and assessing mouse models of diabetic neuropathy.

The antioxidant response as a drug target in diabetic neuropathy.

Membrane traffic and muscle: lessons from human disease.

National Institute of Neurological Disorders and Stroke (NINDS): advances in understanding and treating neuropathy, 24-25 October 2006; Bethesda, Maryland.

Abnormal muscle spindle innervation and large-fiber neuropathy in diabetic mice.

The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) meeting summary: Advances toward measuring diabetic retinopathy and neuropathy: from the bench to the clinic and back again (April 4-5, 2007, Baltimore, Maryland).

Oxidative injury and neuropathy in diabetes and impaired glucose tolerance.

Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.

Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.

Kindlin-2 is required for myocyte elongation and is essential for myogenesis.

Diabetic neuropathy: mechanisms to management.

Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.

Insulin-like growth factors in the peripheral nervous system.

The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy.

Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms.

Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.

SciMiner: web-based literature mining tool for target identification and functional enrichment analysis.

Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.

Disorders of cranial nerves IX and X.

Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis.

Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation.

Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation.

Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.

Computational methods for predicting sites of functionally important dynamics.

Elevated triglycerides correlate with progression of diabetic neuropathy.

Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).

Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.

Patterning N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins.

SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle.

Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.

Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes.

Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.

Mitochondrial DNA (mtDNA) Biogenesis: Visualization and Duel Incorporation of BrdU and EdU Into Newly Synthesized mtDNA In Vitro.

Hyperlipidemia: a new therapeutic target for diabetic neuropathy.

The management of diabetic neuropathy in CKD.

Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.

Accelerated neuritogenesis and maturation of primary spinal motor neurons in response to nanofibers.

The pleotrophic effects of insulin-like growth factor-I on human spinal cord neural progenitor cells.

DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history.

Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy.

Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.

p38 mediates mechanical allodynia in a mouse model of type 2 diabetes.

The role of MTMR14 in autophagy and in muscle disease.

The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice.

Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study.

How does diabetes accelerate Alzheimer disease pathology?

Literature-based discovery of diabetes- and ROS-related targets.

Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs.

Computational methods for identifying a layered allosteric regulatory mechanism for ALS-causing mutations of Cu-Zn superoxide dismutase 1.

Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.

Stem cell technology for the study and treatment of motor neuron diseases.

Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation.

Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes.

Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS.

Diabetic Polyneuropathies: Update on Research Definition, Diagnostic Criteria and Estimation of Severity.

Comment: Career guidelines promote neurologist satisfaction.

Effect of mild hyperglycemia on autonomic function in obstructive sleep apnea.

Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons.

Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network.

Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes.

Skeletal muscle weakness due to deficiency of CuZn-superoxide dismutase is associated with loss of functional innervation.

Stem cell technology for neurodegenerative diseases.

Diabetic neuropathy: cellular mechanisms as therapeutic targets.

The identification of gene expression profiles associated with progression of human diabetic neuropathy.

The Evaluation of Distal Symmetric Polyneuropathy: A Physician Survey of Clinical Practice.

Translational stem cell therapy for amyotrophic lateral sclerosis.

Potential for promoting recurrent laryngeal nerve regeneration by remote delivery of viral gene therapy.

Insulin resistance in the nervous system.

Intraspinal transplantation of neurogenin-expressing stem cells generates spinal cord neural progenitors.

A novel approach to study motor neurons from zebrafish embryos and larvae in culture.

A new member of the multidisciplinary ALS team: The otolaryngologist.